Frequency of CYP2A6 gene deletion and its relation to risk of lung cancer

Chinese Journal of Lung Cancer

Volumn 8, Issue 4, 2005, Pages 297-299

  Gu, Yanfei ^a   Zhang, Shucai ^b   Lai, Baitang ^b   Zhan, Xiuping ^b   Zhang, Yi ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Cytochrome P450 2A6 (CYP2A6); Lung neoplasms; Polymorphism (genetics)

Indexed keywords

CYTOCHROME P450 2A6;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE;

EID: 23944513512     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Smith TJ, Guo Z, Gonzalez FJ, et al. Metabolism of 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Cancer Res, 1992,52(7):1757-1763.
2. Camus AM, Geneste O, Honkakoski P, et al. High variability of nitrosamine metabolism among individuals; role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans. Mol Carcinog, 1993,7(4):268-275.
3. Oscarson M, McLellan RA, Gullsten H, et al. Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population. FEBS Lett, 1999,448(1):105-110.
4. Tan W, Chen GF, Xing DY, et al. Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population. Int J Cancer,2001,95(2):96-101.
5. Hadidi H, Irshaid Y, Vagbo CB, et al. Variability of coumarin 7-and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6. Eur J Clin Pharmacol, 1998,54(5):437-441.
6. Yokoi T, Kamataki T. Genetic polymorphism of drug metabolizing enzymes; new mutations in CYP2D6 and CYP2A6 genes in Japanese. Pharm Res, 1998,15(4):517-524.